|
From Dermatology Times Qbrexza was approved earlier this year for primary axillary hyperhidrosis and now other treatments are being studied. This article summarizes the latest research, which Dr. David Pariser presented at the Fall Clinical Dermatology Conference in Las Vegas last month.
Read more
|